A study of
cancer patients in Washington
State has found they were
twice as likely to file for bankruptcy as people without cancer. The study, led
by researchers from the Fred Hutchinson Cancer Research Center in Seattle,
linked bankruptcy court records and information from the regional cancer
registry on about 200,000 cancer patients, and compared them with a similar
group of people from the same area who did not have cancer. Young people with
cancer experienced the highest bankruptcy rates, the study found, up to 10
times the rate of bankruptcy filings among older age groups.
By Sabrina Tavernise. In The New York Times
Seeking Calm
on the Cancer Ward
When people
choose to have their leukemia treated aggressively, it’s a big commitment, more
so than for almost any other cancer.
With this
therapy — three days of the drug daunorubicin, which comes in a reddish color
so distinctive that one of my patients, a former chemist, used it in his
professional life as a dye for plastics, and seven days of the drug cytarabine,
which is infused continuously over 168 hours — we offer them the chance to be
cured of a disease moving like wildfire with a stiff breeze behind it at the
height of drought.
By Mikkael L. Sekkeres. In The New York Times (blog)
Melanoma
Treatment Harnesses Immune System to Combat Cancer Cells
A study of
cancer patients in Washington
State has found they were
twice as likely to file for bankruptcy as people without cancer. The study, led
by researchers from the Fred Hutchinson Cancer Research Center in Seattle,
linked bankruptcy court records and information from the regional cancer
registry on about 200,000 cancer patients, and compared them with a similar
group of people from the same area who did not have cancer. Young people with
cancer experienced the highest bankruptcy rates, the study found, up to 10
times the rate of bankruptcy filings among older age groups.
By Andrew Pollock. In The New York Times
Cancer
patients condemn hospital care
Some go
hungry, receive the wrong drugs or feel so uncared for they consider abandoning
treatment.
By Denis Campbell. In The Guardian
Cancer
genetics in music and film
“Decoding
Annie Parker,” which premiered in New
York last month, is coming to Seattle June 6 and 8
through SIFF. “In this amazing true story, the lives of cancer-stricken Annie
Parker and UW geneticist Mary-Claire King intertwine, leading to the
world-changing discovery of the BRCA1 breast cancer gene.” Helen Hunt plays
King, and Samantha Morton plays Parker, who now speaks around the world about
her experiences.
By Carol M. Ostrom. In The Seattle
Times
Cancer du sein : le coup de pouce de
Jolie au vendeur de tests génétiques
En annonçant sa mastectomie
préventive, Angelina Jolie a, malgré elle, fait un cadeau à une société
controversée outre-Atlantique : l’action de Myriad Genetics, le fabricant du
test de dépistage, a grimpé de 4% sur une seule journée. Mais Myriad est
poursuivie par des défenseurs des libertés civiles et des scientifiques pour
avoir voulu breveter le vivant.
Par Sophie Caillat. Dans Rue89
Cancer du poumon : une prise de sang
pour repérer les anomalies génétiques
Une équipe de chercheurs français a
mis au point une technique qui permettrait, à l’aide d’une simple prise de
sang, d'identifier les patients susceptibles de bénéficier d'un traitement
ciblé contre le cancer du poumon
Par
Emmanuel Perrin. Dans MaxiSciences
Aucun commentaire:
Enregistrer un commentaire